Literature DB >> 30852734

Bartonella henselae- and quintana-associated uveitis: a case series and approach of a potentially severe disease with a broad spectrum of ocular manifestations.

Dimitrios Kalogeropoulos1, Ioannis Asproudis2, Maria Stefaniotou2, Marilita M Moschos3, Andreas Mentis4, Konstantinos Malamos2, Chris Kalogeropoulos5.   

Abstract

PURPOSE: To evaluate the clinical manifestations of intraocular inflammation associated with Bartonella infection and describe the assessment and management of patients with cat-scratch disease (CSD).
METHODS: This is a retrospective review of the clinical records of patients diagnosed with Bartonella henselae and Bartonella quintana intraocular inflammation from 2011 to 2018 in the Department of Ocular Inflammations and Infections of the University Eye Clinic of Ioannina (Greece). An analysis of the current literature concerning Bartonella-related intraocular infections was also carried out.
RESULTS: This is a retrospective study of 13 patients (7 males and 6 females) with a mean age of 39.2 years that were diagnosed with unilateral intraocular inflammation, except one case with bilateral affection, attributed to Bartonella (either henselae or quintana). Twelve (12) patients (92.3%) had a positive history of traumatic cat contact. The main ocular clinical findings with regard to the type of uveitis included neuroretinitis in 5 eyes (38.5%), vasculitis in 3 eyes (23.1%), iridocyclitis in 2 eyes (15.4%), intermediate uveitis in 2 eyes (15.4%), posterior uveitis in 1 eye (7.7%), panuveitis in 2 eyes (15.4%), retinochoroiditis in 2 eyes (15.4%), vitritis in 1 eye (7.7%), peripheral choroidal granuloma in 1 eye (7.7%). Immunoglobulin (Ig) G was positive in all cases. All patients were treated with antibiotics (mainly rifampicin, doxycycline and azithromycin). The visual acuity was noted to be improved in all patients after treatment, but some of them experienced disturbing complications.
CONCLUSION: CSD may manifest with various ocular pathological findings. Taking into consideration the increasing frequency of infections by B. henselae and B. quintana, clinicians should always incorporate CSD in the differential diagnosis of such presentations of uveitis. Educating vulnerable groups (children, immunosuppressed, etc.) and also general population, the appropriate preventing measures can contribute in limiting the risk of infection.

Entities:  

Keywords:  Bartonella; Cat-scratch disease; Choroidal granuloma; Endophthalmitis; Neuroretinitis; Optic neuropathy; Retinal vasculitis/vascular occlusion; Retinochoroiditis; Uveitis

Mesh:

Year:  2019        PMID: 30852734     DOI: 10.1007/s10792-019-01096-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  38 in total

Review 1.  Ocular manifestations of cat-scratch disease.

Authors:  L D Ormerod; J P Dailey
Journal:  Curr Opin Ophthalmol       Date:  1999-06       Impact factor: 3.761

2.  Cat scratch disease: posterior segment manifestations.

Authors:  W A Solley; D F Martin; N J Newman; R King; D G Callanan; T Zacchei; R T Wallace; D J Parks; W Bridges; P Sternberg
Journal:  Ophthalmology       Date:  1999-08       Impact factor: 12.079

Review 3.  Bartonella-associated infections.

Authors:  D H Spach; J E Koehler
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

4.  Experimental transmission of Bartonella henselae by the cat flea.

Authors:  B B Chomel; R W Kasten; K Floyd-Hawkins; B Chi; K Yamamoto; J Roberts-Wilson; A N Gurfield; R C Abbott; N C Pedersen; J E Koehler
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

Review 5.  Neuroretinitis: a review.

Authors:  Aliaa Abdelhakim; Nailyn Rasool
Journal:  Curr Opin Ophthalmol       Date:  2018-11       Impact factor: 3.761

6.  Retinal artery occlusion due to Bartonella henselae infection: a case series.

Authors:  Maya Eiger-Moscovich; Radgonde Amer; Merih Oray; Khalid F Tabbara; Ilknur Tugal-Tutkun; Michal Kramer
Journal:  Acta Ophthalmol       Date:  2016-01-08       Impact factor: 3.761

7.  Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test.

Authors:  K M Zangwill; D H Hamilton; B A Perkins; R L Regnery; B D Plikaytis; J L Hadler; M L Cartter; J D Wenger
Journal:  N Engl J Med       Date:  1993-07-01       Impact factor: 91.245

Review 8.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

Review 9.  Bartonella spp. - a chance to establish One Health concepts in veterinary and human medicine.

Authors:  Yvonne Regier; Fiona O Rourke; Volkhard A J Kempf
Journal:  Parasit Vectors       Date:  2016-05-10       Impact factor: 3.876

10.  Clinical Profile and Visual Outcome of Ocular Bartonellosis in Malaysia.

Authors:  Chai Lee Tan; Lai Chan Fhun; Evelyn Li Min Tai; Nor Hasnida Abdul Gani; Julieana Muhammed; Tengku Norina Tuan Jaafar; Liza Sharmini Ahmad Tajudin; Wan-Hazabbah Wan Hitam
Journal:  J Trop Med       Date:  2017-02-07
View more
  3 in total

1.  Spirochetal uveitis: Spectrum of clinical manifestations, diagnostic and therapeutic approach, final outcome and epidemiological data.

Authors:  Dimitrios Kalogeropoulos; Ioannis Asproudis; Maria Stefaniotou; Marilita Moschos; Constantina Gartzonika; Ioannis Bassukas; Spiros Konitsiotis; Haralampos Milionis; Georgios Gaitanis; Konstantinos Malamos; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

2.  Bartonella quintana Infection Manifesting as Leucocytoclastic Vasculitis Rash.

Authors:  Brian J Hopkins; Bonnie C Prokesch
Journal:  Open Forum Infect Dis       Date:  2021-07-06       Impact factor: 3.835

3.  Pediatric Bartonella henselae neuroretinitis masking co-infections.

Authors:  Gina Pham; Christopher R Dermarkarian; Jeffrey Tran; Veeral S Shah
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.